Summary
We have developed a new method of detecting islet cell antibodies using peroxidase-labeled protein A, and have determined the incidence of ICA in Type 1 (insulin-dependent) diabetes in Japan. In our method, fresh frozen sections of human pancreas and serum samples were incubated and then treated with peroxidase-labeled protein A at room temperature. Conjugates of peroxidase and protein A were subjected to Sephadex G-200 column chromatography, and only the 80,000 dalton peak was employed. The treated sections were allowed to react with haematoxylin and eosin (HE) to confirm the localization of islet cells. With this method, human pancreatic tissues can be used regardless of age and blood type, and the stained sections can be stored for more than 5 years. Serum samples obtained from 52 patients with Type 1 diabetes, 54 with Type 2 (non-insulin-dependent) diabetes and 100 control subjects were examined. In patients with Type 1 diabetes, islet cell antibodies were detected in 14 of 14 (0.5 years after onset), 3 of 6 (0.5–1 years after onset), 7 of 16 (1–5 years after onset) and 2 of 16 (more than 5 years after onset). In contrast, only 4 of 54 patients with Type 2 diabetes and none of the controls were ICA positive. It is concluded that, with our newly developed method using peroxidase-labeled protein A, ICA is present in all Japanese Type 1 diabetic patients whose diabetic manifestations are less than 0.5 years duration from onset.
Article PDF
Similar content being viewed by others
References
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1283
MacCuish AC, Barnes EW, Irvine WJ, Duncan LJP (1974) Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 2: 1529–1531
Bottazzo GF, Pujol-Borrell R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1: 139–159
Irvine WJ (1979) Immunological aspects of diabetes mellitus. In: Pierluissi J (ed) Endocrine pancreas and diabetes. Excerpta Medica, Amsterdam, pp 281–299
Roitt IM, Doniach D (1969) Immunofluorescent test for the detection of autoantibodies. In: WHO Manual of Autoimmune Serology. World Health Organization, Geneva
Lendrum R, Walker G (1975) Serum antibodies in human pancreatic disease. Gut 16: 365–371
Nakane PK, Kawaoi A (1974) Peroxidase-labeled antibodody, a new method of conjugation. J Histochem 22: 1084–1091
Engel AG, Lindstrom JM, Lambert EH, Lennon VA (1971) Ultrastructual localization of the acetylcholine receptor in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 183–46
Karnovsky MJ (1967) The ultrastructural basis of capillary permeability studied with a peroxidase tracer. J Cell Biol 35: 213–236
Lendrum R, Walker G, Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1: 880–883
Lendrum R, Walker G, Cudworth AG, Theoohanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet-cell antibodies in diabetes mellitus. Lancet 2:1273–1276
Prete GFD, Betterle C, Padovan D, Erle G, Toffolo A, Bersahi G (1977) Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus. Diabetes 26: 909–915
Barbosa J, Chavers B, Dunsworth T, Michael A (1982) Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives. Diabetes 31: 585–588
Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, Rosenbloom AL (1980) Islet cell and other organ-specific antibodies in U.S. caucasians and blacks with insulin-dependent diabetes mellitus. Diabetes 29: 589–592
Bruining GJ, Molenaar J, Tuk CW, Lindeman J, Bruining HA, Marner B (1984) Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes. Diabetologia 26: 24–29
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhal JW, Vaughan H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138–147
Kobayashi T, Sawano S, Itoh T, Sugimoto T, Takahashi S, Tanaka T, Suwa S (1982) Islet-cell antibodies in insulin dependent and non-insulin-dependent diabetics in Japan: their prevalence and clinical significance. In: Mimura G, Baba S, Goto Y, Kobberling J (eds) Clinico-genetic genesis of diabetes mellitus. International Congress Series No. 597. Excerpta Medica, Amsterdam Princeton London, pp 150–160
Sakurami T, Nagaoka K, Nabeya N, Hisano S (1981) ICA (islet cell antibodies) Diabetes 19: 58–63 (in Japanese)
Marner B, Lernmark A, Nerup J, Molenaar JL, Tuk CW, Bruining GJ (1983) Analysis of islet cell antibodies on frozen sections of human pancreas. Diabetologia 25: 93–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, A., Tsujihata, M., Yokota, A. et al. A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in Type I (insulin-dependent) diabetes. Diabetologia 29, 378–382 (1986). https://doi.org/10.1007/BF00903348
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00903348